112 related articles for article (PubMed ID: 16840184)
1. Late-onset neutropenia following rituximab.
McLaughlin P
Leuk Lymphoma; 2006 Jun; 47(6):965-6. PubMed ID: 16840184
[No Abstract] [Full Text] [Related]
2. Delayed-onset neutropenia associated with rituximab therapy.
Chaiwatanatorn K; Lee N; Grigg A; Filshie R; Firkin F
Br J Haematol; 2003 Jun; 121(6):913-8. PubMed ID: 12786803
[TBL] [Abstract][Full Text] [Related]
3. Lymphocyte subpopulation imbalances, bone marrow hematopoiesis and histopathology in rituximab-treated lymphoma patients with late-onset neutropenia.
Stamatopoulos K; Papadaki T; Pontikoglou C; Athanasiadou I; Stavroyianni N; Bux J; Batsis I; Pyrovolaki K; Paterakis G; Anagnostou D; Anagnostopoulos A; Papadaki HA
Leukemia; 2008 Jul; 22(7):1446-9. PubMed ID: 18185527
[No Abstract] [Full Text] [Related]
4. Late-onset neutropenia after rituximab treatment: case series and comprehensive review of the literature.
Wolach O; Bairey O; Lahav M
Medicine (Baltimore); 2010 Sep; 89(5):308-318. PubMed ID: 20827108
[TBL] [Abstract][Full Text] [Related]
5. Late-onset neutropenia following viral bone marrow depression after rituximab therapy.
Christopeit M; Haak U; Behre G
Ann Hematol; 2008 Sep; 87(9):761-2. PubMed ID: 18350295
[No Abstract] [Full Text] [Related]
6. Late-onset neutropenia in patients treated with rituximab for non-Hodgkin's lymphoma.
Fukuno K; Tsurumi H; Ando N; Kanemura N; Goto H; Tanabashi S; Okamoto K; Moriwaki H
Int J Hematol; 2006 Oct; 84(3):242-7. PubMed ID: 17050199
[TBL] [Abstract][Full Text] [Related]
7. Late-onset neutropenia associated with rituximab therapy: evidence for a maturation arrest at the (pro)myelocyte stage of granulopoiesis.
Tesfa D; Gelius T; Sander B; Kimby E; Fadeel B; Palmblad J; Hägglund H
Med Oncol; 2008; 25(4):374-9. PubMed ID: 18278570
[TBL] [Abstract][Full Text] [Related]
8. The late adverse events of rituximab therapy--rare but there!
Ram R; Ben-Bassat I; Shpilberg O; Polliack A; Raanani P
Leuk Lymphoma; 2009 Jul; 50(7):1083-95. PubMed ID: 19399690
[TBL] [Abstract][Full Text] [Related]
9. Evidence for T-large granular lymphocyte-mediated neutropenia in Rituximab-treated lymphoma patients: report of two cases.
Papadaki T; Stamatopoulos K; Stavroyianni N; Paterakis G; Phisphis M; Stefanoudaki-Sofianatou K
Leuk Res; 2002 Jun; 26(6):597-600. PubMed ID: 12007508
[TBL] [Abstract][Full Text] [Related]
10. Neutropenia associated with rituximab therapy.
Grant C; Wilson WH; Dunleavy K
Curr Opin Hematol; 2011 Jan; 18(1):49-54. PubMed ID: 21102324
[TBL] [Abstract][Full Text] [Related]
11. Delayed-onset peripheral blood cytopenia after rituximab: frequency and risk factor assessment in a consecutive series of 77 treatments.
Cattaneo C; Spedini P; Casari S; Re A; Tucci A; Borlenghi E; Ungari M; Ruggeri G; Rossi G
Leuk Lymphoma; 2006 Jun; 47(6):1013-7. PubMed ID: 16840190
[TBL] [Abstract][Full Text] [Related]
12. Early onset neutropenia after rituximab in lupus nephritis.
Enríquez R; Borrás-Blasco J; Sirvent AE; Masía M; Amorós F
Clin Exp Rheumatol; 2007; 25(2):345. PubMed ID: 17543172
[No Abstract] [Full Text] [Related]
13. Is rituximab-induced late-onset neutropenia a good prognostic indicator in lymphoproliferatve disorders?
Hincks I; Woodcock BE; Thachil J
Br J Haematol; 2011 May; 153(3):411-3. PubMed ID: 21275972
[No Abstract] [Full Text] [Related]
14. Neutropenia in patients treated with rituximab.
Voog E; Morschhauser F; Solal-Céligny P
N Engl J Med; 2003 Jun; 348(26):2691-4; discussion 2691-4. PubMed ID: 12826650
[No Abstract] [Full Text] [Related]
15. Delayed-onset neutropenia in a patient receiving rituximab as treatment for refractory kidney transplantation.
Mitsuhata N; Fujita R; Ito S; Mannami M; Keimei K
Transplantation; 2005 Nov; 80(9):1355. PubMed ID: 16314808
[No Abstract] [Full Text] [Related]
16. Neutropenia after rituximab treatment: new insights on a late complication.
Wolach O; Shpilberg O; Lahav M
Curr Opin Hematol; 2012 Jan; 19(1):32-8. PubMed ID: 22080846
[TBL] [Abstract][Full Text] [Related]
17. Rituximab-related cryptogenic organizing pneumonia and late onset neutropenia in a patient with non-Hodgkin lymphoma: report of two rare complications and review of the literature.
Urun Y; Dincol D; Kumbasar OO
J BUON; 2012; 17(3):602-3. PubMed ID: 23033310
[No Abstract] [Full Text] [Related]
18. Late-onset neutropenia following rituximab therapy: incidence, clinical features and possible mechanisms.
Tesfa D; Palmblad J
Expert Rev Hematol; 2011 Dec; 4(6):619-25. PubMed ID: 22077526
[TBL] [Abstract][Full Text] [Related]
19. Severe hematological side effects following Rituximab therapy in children.
Larrar S; Guitton C; Willems M; Bader-Meunier B
Haematologica; 2006 Aug; 91(8 Suppl):ECR36. PubMed ID: 16923520
[TBL] [Abstract][Full Text] [Related]
20. Fatal cytokine release syndrome with chimeric anti-CD20 monoclonal antibody rituximab in a 71-year-old patient with chronic lymphocytic leukemia.
Lim LC; Koh LP; Tan P
J Clin Oncol; 1999 Jun; 17(6):1962-3. PubMed ID: 10561242
[No Abstract] [Full Text] [Related]
[Next] [New Search]
